Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-03-05

FDA Approved: GABAPENTIN — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Gabapentin from Aurobindo Pharma Limited, enabling the generic product's continued marketing under the approved labe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

SUPPL AP for GABAPENTIN (GABAPENTIN)